Acetylcysteine
NDC 63323-692, ACETYLCYSTEINE, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-692
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- SOLUTION
- Route
- ORAL, RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203853
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-692 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETYLCYSTEINE200 mg/mL
Pharmacologic classes
Antidote [EPC]; Antidote for Acetaminophen Overdose [EPC]; Decreased Respiratory Secretion Viscosity [PE]; Increased Glutathione Concentration [PE]; Mucolytic [EPC]; Reduction Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-692-10 | 63323069210 | 3 VIAL in 1 CARTON (63323-692-10) / 10 mL in 1 VIAL (63323-692-22) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/75b48fab-cef6-465c-a1e0-d085b3988bc4Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-692
Use it
Look up 63323-692 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-692 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-692. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.